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Genetic Polymorphisms are the variations found in the DNA sequences and they are 
integral to the development of genetic markers to identify individuals at risk.  The 
genotypic distribution of various genetic polymorphisms involved in essential 
hypertension (EHT) and type 2 diabetes mellitus subjects (T2DM) has been 
established in many populations with conflicting results but in Malaysian subjects it 
has not been well characterized. The main objective of this study was to determine 
the association of various polymorphisms involved in the renin angiotensin-
aldosterone system (RAAS), insulin receptor, lipoprotein lipase, interleukin gene and 
G protein ß 3 subunit genes in EHT and T2DM of Malaysian subjects. This cross-
sectional study includes 70 EHT without T2DM, 60 T2DM, 65 EHT with T2DM and 
75 unrelated healthy control subjects. Genomic DNA was extracted from the 
peripheral blood and the plasma was separated and analyzed for the biochemical 
analyses. The genotypes of the various genetic polymorphisms were determined 
using the polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP), mutagenically PCR and the hot-start PCR methods. All PCR products 
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and the restricted fragments were resolved electrophoretically on agarose and 
polyacrylamide gels. Statistical analyses was done using SPPS version 14.0. The 
baseline characteristics such as age, body mass index, diastolic blood pressure, 
fasting plasma glucose, high density lipoprotein cholesterol and sodium differed 
significantly (p<0.05) in case subjects compared to control subjects but not in low 
density lipoprotein cholesterol, total cholesterol and potassium. The 
insertion/deletion (I/D) and G2350A polymorphism of the angiotensin converting 
enzyme (ACE) gene and the I/D polymorphism of the alpha adrenoceptor gene 
differed significantly in EHT and T2DM subjects, whereas the A6G variant of the 
angiotensinogen (AGT) gene differed significantly (p<0.05) in the EHT and 
EHT+T2DM subjects when compared to the control subjects but not in the T2DM 
subjects. However, the BglI and MboI polymorphisms of the renin gene, the A6244G 
polymorphism of the insulin receptor gene, the S477X polymorphism of the 
lipoprotein lipase gene, the C511T polymorphism of the interleukin gene and the 
C825T polymorphism of the G protein ß 3 subunit genes did not differ significantly 
(p>0.05) when compared to the control subjects. Therefore, the polymorphisms of 
ACE, AGT and alpha adrenoceptor genes involved in RAAS were significantly 
associated with EHT and T2DM in Malaysian subjects. The genotypes and alleles of 
those polymorphisms can be considered as possible genetic markers or predisposing 
risk factors for EHT and T2DM in Malaysian subjects.     
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Polimorfisme genetik adalah variasi yang terdapat di dalam jujukan DNA dan 
penting bagi pembentukan penanda-penanda genetik untuk mengenalpasti individu-
individu yang berisiko. Taburan genotip bagi pelbagai polimorfisme genetik yang 
terlibat dalam hipertensi primer dan kencing manis jenis kedua telah ditubuhkan 
melalui kajian ke atas pelbagai populasi dengan keputusan yang bertentangan tetapi 
pesakit-pesakit di Malaysia belum dicirikan sepenuhnya lagi. Objektif utama kajian 
ini adalah untuk menentukan hubungan pelbagai polimorfisme yang terlibat dalam 
sistem renin angiotensi-aldosteron (RAAS), reseptor insulin, lipoprotein lipase, gen 
interleukin dan gen protein G beta 3 sub-unit di dalam hipertensi primer dan kencing 
manis jenis kedua dalam pesakit di Malaysia. Kajian keratan-lintang ini melibatkan 
70 orang pesakit hipertensi primer, 60 orang pesakit kencing manis jenis kedua, 65 
orang pesakit hipertensi primer dengan kencing manis jenis kedua dan 75 orang yang 
sihat sebagai kawalan. DNA genomik telah diekstrak daripada darah dan plasma 
telah diasingkan bagi analisis biokimia. Genotip pelbagai polimorfisme genetik telah 
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ditentukan menggunakan kaedah tindak balas rantaian polimerase polimorfisme 
panjang jalur terpotong (PCR-RFLP), tindak balas rantaian polimerase mutagenic 
(MS-PCR) dan tindak balas rantaian polimerase Hot-Start (Hot-Start PCR). Semua 
produk tindak balas rantaian polimerase (PCR) dan fragmen potongan (RFLP) telah 
ditentukan menggunakan elektroforesis gel agarosa dan gel poliakrilamida. Semua 
analisa statistik telah dilakukan menggunakan SPSS versi 14.0. Ciri-ciri asas seperti 
umur, indeks jisim tubuh, tekanan darah diastol, plasma glukos puasa, kolesterol 
lipoprotein berketumpatan tinggi dan natrium adalah signifikan (p<0.05) manakala 
kolesterol lipoprotein berketumpatan rendah, jumlah kolesterol dan kalium adalah 
tidak signifikan (p>0.05). Polimorfisme penambahan/pengurangan G2350A bagi gen 
enzim penukaran angiotensin (ACE), polimorfisme penambahan/pengurangan bagi 
gen Alfa Adrenoreseptor dan polimorfisme A6G bagi gen Angiotensinogen adalah 
signifikan (p<0.05). Walau bagaimanapun, polimorfisme BgII dan MboI bagi gen 
renin, polimorfisme A6244G bagi gen insulin reseptor, polimorfisme S477X bagi 
gen lipoprotein lipase, polimorfisme C511T bagi gen interleukin dan polimorfisme 
C825T bagi gen protein G beta 3 sub-unit adalah tidak signifikan (p>0.05) apabila 
dibandingkan dengan normal. Oleh yang demikian , polimorfisme bagi gen ACE, 
AGT, dan Alfa Adrenoreseptor yang terlibat dalam sistem renin angiotensin-
aldosteron mempunyai hubungan dengan pesakit hipertensi primer dan kencing 
manis jenis kedua di Malaysia. 
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CHAPTER 1 
 
INTRODUCTION 
 
Background of the Study 
 
Genetic polymorphism is defined as the inheritance of a trait controlled by a single 
genetic locus with two alleles, in which the least common allele has a frequency of 
about 1% or greater (Gelehrler and Collins, 1990). Several studies have been done in 
understanding the possible role of genetic variation in the human genome. 
Identifying the relationship between the ancestral variants in genes are common in 
polygenic diseases become increasingly feasible with improved methods for finding 
DNA sequence variants on a genome-wide scale (Collins et al., 1998; Landegren et 
al., 1998).  
 
Most of the variations found in DNA sequence are stable and occur in the form of 
single nucleotide polymorphism (SNPs), insertion/deletion (I/D) and variable tandem 
repeats. SNPs are stable, they are di-allelic, the two alleles representing the “wild-
type” and the “mutant type” form (Doris et al., 2002). Variation occurs when a single 
nucleotide (A, T, C, or G) alters in the genome sequence. Common sequence variants 
occur in about 1 in every 1000 bases of coding/ regulatory sequence. In every gene 
there is an average of 4-8 SNPs occurring either in the exons or coding regions or in 
the nearby exons and introns boundaries in the upstream regulatory regions. Each 
person would be heterozygous for 24,000-40,000 non-synonymous (amino acid 
altering) substitutions (Lele et al., 2003). The genetic polymorphisms are integral to 
the development of genetic markers to identify the individuals at risk of developing 
the diseases. To identify the common disease susceptibility loci, many studies 
encompassing genome-wide association mapping, linkage (Krushkal et al., 1999), 
candidate gene association (Yamada et al., 2002) have been utilized.  It has been 
realized that genetic susceptibility to the common complex disorders probably 
involves many genes, most of which have small effects (Cordell and Clayton, 2005). 
 
 Various genetic polymorphisms in the candidate genes encoding proteins 
with known biochemical or physiologic function for blood pressure regulation have 
been identified in various populations with contradictory results (Agarwal et al., 
2005). Nearly 30-50% variations in genetic elements contribute to the dysregulation 
of blood pressure in human essential hypertension (Garcia et al., 2003).  Essential 
hypertension (EHT) is a multifactorial disease, and a number of risk factors 
underlying hypertension including age, sex, family history of hypertension, 
demographic factors, weight, diabetes mellitus, excess consumption of sodium, 
physical inactivity, smoking, and excess coffee and alcohol consumption have been 
identified (Chalmers et al., 1999).  
 
Type 2 diabetes mellitus (T2DM) is a complex heterogeneous group of 
conditions characterized by the elevated levels of plasma glucose, caused by 
impairment in both insulin secretion and resistance to insulin action (Radha et al., 
2007). It is a very common metabolic disorder with a substantial inherited 
component.  
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Undiagnosed or poorly control diabetes will lead to multitude of complications such 
as diabetic retinopathy, nephropathy, neuropathy and increased cardiovascular 
morbidity and mortality (Klein, 1995). A number of other risk factors underlying 
EHT and T2DM have also been identified including age, sex, genetics, demographic 
factors and others. 
   
The genetics of the common variety of hypertension (HPT) and T2DM also 
called polygenic or multifactorial disease is a result of the interaction between the 
environment and multiple genes. The susceptibility is associated with frequent 
polymorphisms that create variation in exons or influence the expression of genes in 
the regulatory parts (McCarthy et al., 2002). These sequence variants are associated 
with a limited increase in the risk of developing the disease. They can be considered 
as susceptibility variants, but by themselves are not causative factors that are 
unambiguous to determine the disease. 
 
  Several research strategies have been utilized to dissect the genetic variants of 
both EHT and T2DM predisposition genetic loci, including investigations of specific 
candidate genes, genome-wide searches, and the use of intermediate phenotypes, 
comparative genomics, and a combination of these methods (Timberlake et al., 2001; 
Tanira et al., 2005). One such research strategy is the ‘candidate gene’ approach and 
one of the most extensively studied in EHT and T2DM pathogenesis. The molecular 
events in diabetes pathogenesis have been examined directly by testing the role of 
sequence variants of specific candidate genes (McCarthy et al., 2002). The candidate 
gene approach focuses on the search for an association between the disease and 
sequence variants in or near biologically defined candidate genes which have been 
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chosen based on their known physiological function. The candidate gene approach is 
useful for quickly determining the association of a genetic variant with a disorder and 
for identifying genes of modest effect. This approach has certain advantages over 
traditional linkage mapping or positional cloning approaches (Kwon et al., 2000).  
   
The association studies, most of which use the cross-sectional and case-
control designs with groups of unrelated individuals, are designed to detect 
associations between disease and specific alleles. Alleles of these polymorphisms are 
present in both healthy individuals and patients, although with different frequencies 
(Timberlake et al., 2001). Consistent with the very large numbers of studies, many 
have shown modest associations in single population, but these associations have not 
yet been replicated in other populations (Radha et al., 2007). Unfortunately, to date, 
there is no clear picture as to the genetic determinants of EHT and T2DM, in part, 
due to the conflicting results even in the same gene polymorphism.  
 
A number of laboratory techniques have been developed in recent years to 
analyze DNA rapidly with the advent of Polymerase Chain Reaction (PCR) and 
reliably for the purpose of mutation detection (Grompe, et al., 1993). One of the 
methods involves in detecting the mutation is Restriction Fragment Length 
Polymorphism (RFLP). RFLP is a method that uses specific restriction 
endonucleases to detect the differences in homologous DNA sequences by the 
presence or absence of different length of restriction fragments. RFLP method can be 
used to determine the disease status of an individual. PCR is a method of amplifying 
and enriching small amounts of DNA within a targeted region of a DNA sequence. 
When the two procedures are combined, the method is referred to as PCR-RFLP. 
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Many successful studies have been done to detect the genetic polymorphism in 
various populations in association with EHT and T2DM using PCR-RFLP method 
(Fabris et al., 2005). This cross-sectional study mainly focuses on determining the 
association between genetic polymorphism of susceptibility genes and predisposition 
to EHT and T2DM subjects. 
 
 
Problem Statement 
 
Hypertension and T2DM is a major contributor to cardiovascular disease which is 
the leading cause of death in Malaysia. According to the Second National Health 
Morbidity Survey 1996 (NHMSII, 1996) in Malaysia, the prevalence of HPT among 
adults was found to be 33%, 8.3% for T2DM and for impaired glucose tolerance it 
was 4.3%. But a recent survey shows that, the current prevalence of hypertension 
registered a rise of 30% (33% vs 43%) and for known and newly diagnosed diabetes 
among adults above 30 years rose from 8.3% to 14.9% (NHMS III, 2006).  In future 
it faces the daunting prospect of even higher prevalence of HPT as well as T2DM. 
While environmental factors also certainly play a major role in the hypertension and 
diabetes epidemic, this usually occurs on a background of genetic susceptibility. 
Several studies have been carried out to determine the candidate genes in 
predisposition to EHT and T2DM in various populations with conflicting results. 
Since genetic diversity exists among different ethnic populations and realizing the 
fact that the association in one population could not be extrapolated to another 
population.  In Malaysia, there is a lack of data is available on the association of the 
genetic polymorphisms with EHT and T2DM. This stimulated us to study the 
association of genetic polymorphisms in relation to EHT and T2DM. 
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Significance of the Study 
 
Identifying EHT and T2DM susceptibility genes will help us in 
understanding the pathophysiology of the disease. In addition to the potential impact 
of genomic information in selecting suitable anti-hypertensive and the anti-diabetic 
drug therapy, it may also help in recognizing those at the risk of developing the 
disease, which may lead to new preventive approaches. This cross-sectional study 
attempts to determine the presence of known genetic variations of candidate genes 
that may be implicated in the pathogenesis of EHT and T2DM.  It also highlights 
some of the opportunities and challenges, which may be encountered in interpreting 
the value of these genetic variations to improve the management of EHT and T2DM. 
Association analyses are performed by comparing cases and controls for differences 
in presumed risk factors, like alleles. The association could be attributable to chance, 
artifact, or selection bias. Population stratification (namely the separation of a study 
population into subgroups) is often a confounding factor. Most genetic studies of 
hypertension-predisposing genetic loci have used this strategy to study the candidate 
genes. This systematic approach assumes that a gene or a set of genes involving a 
specific physiological or cellular function contribute to blood pressure variation.  
Most of the studies utilized genetic linkage and association methods and enrolled 
unrelated individuals. The cross-sectional study design also renders candidate gene 
studies less likely to be reproducible and less expected to include all causative genes 
and polymorphisms. The candidate gene analysis would provide a better approach 
for identifying the genotype–phenotype correlations. The candidate gene study is 
more effective than linkage analysis in studying EHT and T2DM since it has greater 
statistical power to detect several genes for small effect.  Identification of the 
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contributing genes will allow us to recognize those vulnerable individuals, and to 
classify the patients in subgroups with definite genetic and pathogenic mechanisms, 
which might enable the use of genotypes to identify more-specific therapeutic and 
preventative measures for EHT and T2DM. The current study is conducted to 
determine the association of genetic polymorphisms of candidate genes involved in 
EHT and T2DM and the distribution of risk factors among Malaysian subjects.  
 
 
Hypothesis 
 
Genetic polymorphism of certain susceptibility genes is a risk factor or not 
for EHT and T2DM in Malaysian subjects.  
 
 
Main Objective  
 
To determine the association of genetic polymorphisms of susceptibility genes 
involved in Malaysian essential hypertensive and type 2 diabetic subjects.  
 
 
Specific Objectives 
 
1. To determine the genotypic and allelic frequencies of genetic polymorphisms 
of candidate genes in essential hypertensive subjects. 
2. To determine the genotypic and allelic frequencies of genetic polymorphisms 
of candidate genes in type 2 diabetic subjects. 
3. To determine the association of genetic polymorphisms between the case and 
control subjects. 
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